Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-02-18
1977-06-14
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260453RW, 2605005H, 260559T, 424320, 424324, A61K 3121, A61K 31165, C07C11920
Patent
active
040298124
ABSTRACT:
Novel 2-((3,5-di-tert-butyl-4-hydroxyphenyl)-thio)carboxamides and compositions containing the compounds are disclosed. A method for reducing blood serum lipids using the compounds and compositions of the invention is also disclosed.
REFERENCES:
patent: 2681363 (1954-06-01), Schwenk et al.
patent: 3369025 (1968-02-01), Bolhofer
patent: 3383411 (1968-05-01), Schultz et al.
patent: 3652646 (1972-03-01), Leigh et al.
patent: 3707549 (1972-12-01), Mills
patent: 3716644 (1973-02-01), Alberts et al.
patent: 3732295 (1973-05-01), Dompe
Metz et al., vol. 82, (1975), 43,070h.
Holland, vol. 82, (1975), 16,563q.
Kuroda et al., vol. 80, (1974), 133,072y.
Kuroda et al., vol. 80, (1974), 133,073z.
Mueller Larry G.
Wagner Eugene R.
Ambrosius James W.
Robinson Allen J.
The Dow Chemical Company
LandOfFree
Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio ca does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio ca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio ca will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-10886